allulose sugar glp-1 Release by Rare D-Allulose Ameliorates Sucrose-Induced Obesity and Glucose Intolerance in Ovariectomized Mice Secretion of GLP-1 but not
Description
In an update posted on its website on 2 January 2024, the US FDA confirmed that it was carrying out the []
elife
In clinical trials, it led to a weight reduction of up to 16.2%
Everyone is talking about GLP-1s, but the people taking them
The science, promise and clinical development of GLP-1 and GIP receptor agonists in obesity
I designed this schematic on BioRender to visualize what I think is happening to my patients
